NCT04947267View on ClinicalTrials.gov

To Compare the Pulpal Oxygen Saturation Level After Administering Mepivacaine With and Without Vasoconstrictor

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 30, 2018

Primary Completion Date

September 21, 2019

Study Completion Date

November 19, 2019

Conditions
LOCAL ANESTHESIA
Interventions
DRUG

3% Mepivacaine Hydrochloride

1.8 ml of 3% mepivacaine (3% Scandonest, Septodont) was administered to Group B patients. Inferior alveolar nerve block was administered to both the groups. Rubber dam was then placed in the desired quadrant. Selected carious mandibular was restored and seven pulpal oxygen saturation spot readings were taken for an hour.

DRUG

2% Mepivacaine with 1:100,000 epinephrine

1.8 ml of 2% mepivacaine with 1:100,000 epinephrine (2% Scandonest Special, Septodont) was administered to Group A patients. Inferior alveolar nerve block was administered to both the groups. Rubber dam was then placed in the desired quadrant. Selected carious mandibular was restored and seven pulpal oxygen saturation spot readings were taken for an hour.

Trial Locations (1)

Unknown

Dow University of Health Sciences, Karachi

All Listed Sponsors
lead

Afshan Amjad Ali

OTHER

NCT04947267 - To Compare the Pulpal Oxygen Saturation Level After Administering Mepivacaine With and Without Vasoconstrictor | Biotech Hunter | Biotech Hunter